News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research> UBS Lowers TP of CHINA BIOPHARMACEUTICAL (01177.HK) to HKD11, Rating 'Buy'
UBS released a research report stating that CHINA BIOPHARMACEUTICAL (01177.HK) recorded a revenue of RMB31.8 billion last year, representing a year-on-year increase of 10.3%, which...
Reset
Send
The window will close in 5 seconds
<Research> UBS Lowers TP of CHINA BIOPHARMACEUTICAL (01177.HK) to HKD11, Rating 'Buy'
Close
Recommend
13
Positive
19
Negative
9
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

UBS released a research report stating that CHINA BIOPHARMACEUTICAL (01177.HK)  -0.030 (-0.472%)    Short selling $142.91M; Ratio 75.915%   recorded a revenue of RMB31.8 billion last year, representing a year-on-year increase of 10.3%, which was below expectations. The net profit reached RMB2.3 billion, up 22% year-on-year, also below expectations. The gross profit margin increased by 0.6 percentage points year-on-year to 82.1%. The management expects that driven by the continuous growth of innovative products, this year's revenue and profit will achieve double-digit growth.

The firm raised the EPS forecast for CHINA BIOPHARMACEUTICAL for this year by 9.4%. However, due to lower expected revenue and profitability from generic drugs, it lowered the EPS forecasts for 2027 and 2028. Additionally, the company's target price was reduced from HKD12.2 to HKD11, reaffirming the 'Buy' rating. (ca/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Related News CLSA Lowers TP for CHINA BIOPHARMACEUTICAL (01177.HK) to HKD8.9, New Product Launches and Platform Expansion Support Next Phase Growth



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.